• Ping An Biomedical received a second 180-day Nasdaq grace period to regain the $1 minimum bid price, extending the deadline to Nov. 23, 2026.
• Nasdaq will close the matter if the stock trades at or above $1 for at least 10 consecutive business days during the period.
• A reverse stock split is under consideration as part of the plan to regain compliance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ping An Biomedical Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-061559), on May 27, 2026, and is solely responsible for the information contained therein.